OpenNeedle Ask your own

Question explored with the scientific record

Conversation so far

  1. 1 side effects of diphenhydramine
  2. 2 Explain anticholinergic
  3. 3 How can I tell if diphenhydramine is causing anticholinergic effects?

Answered on this page ↓

How can I tell if diphenhydramine is causing anticholinergic effects?

Nov 21, 2026 · 5 sources used · OpenNeedle synthesis
The short version: watch for a dry mouth, trouble peeing, constipation, blurry vision, and a foggy or drowsy head. Those are the anticholinergic signs, and diphenhydramine produces them.

The clearest signal is urinary retention. A 66-year-old man who took diphenhydramine developed trouble emptying his bladder, which then set off a dangerous chain of events [4]. If you notice you cannot pee, or it comes in dribbles, that is a real anticholinergic effect, not a coincidence.

The second signal is the brain. Diphenhydramine is sedating, and drowsiness is a poor guide to how impaired you actually are. In a driving-simulator trial, driving was worst after diphenhydramine, and people's own drowsiness ratings did not predict their impairment [5]. So do not trust "I feel fine" as evidence you are fine.

There is a genuine puzzle in the memory data. In one study of 50 healthy adults, scopolamine clearly impaired recall while diphenhydramine at 25 and 50 mg did not, despite both causing sedation [3]. Yet in another study, diphenhydramine 50 mg did lower total recall on a memory test [1]. The two studies disagree, which means the cognitive effect is real but inconsistent and dose-dependent.

SignWhat it looks like
Dry mouth, dry eyesNo saliva, gritty eyes
Urinary retentionCannot pee, or dribbling [4]
ConstipationHard, infrequent stools
Blurred visionTrouble focusing near
Confusion, sedationFoggy head, poor driving [5]

A rare but serious sign is a movement reaction. One case describes acute dystonia, with muscle spasms, a fixed downward stare, and slurred speech, starting within minutes of an intravenous dose [2]. That is an emergency.

My call: if you have dry mouth plus trouble peeing or a foggy head after a dose, that is anticholinergic effect, and the drug is doing it. Confidence: high on the urinary and sedation signs, moderate on the memory effect, since the studies disagree [1][3].

Keep digging

Sources used 5

  1. Identification of Medications That Cause Cognitive Impairment in Older People: The Case of Oxybutynin Chloride Journal of the American Geriatrics Society (1998) Thin

    This study evaluates the cognitive effects of oxybutynin hydrochloride in older adults, demonstrating significant cognitive impairment compared to diphenhydramine and highlighting the need for monitoring cognitive performance in patients prescribed this medication.

    DOI: 10.1111/j.1532-5415.1998.tb01006.x
  2. Diphenhydramine‐Induced Acute Dystonia Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy (1994) Thin

    Diphenhydramine can trigger rapid-onset acute dystonia in adults, as shown by a single case where intravascular diphenhydramine precipitated dystonic symptoms within minutes and resolved with anti-dystonia treatment.

    DOI: 10.1002/j.1875-9114.1994.tb02842.x
  3. Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine Psychopharmacology (1998) Thin

    This study investigates the differential effects of scopolamine, lorazepam, and diphenhydramine on memory and event-related potentials (ERPs) in healthy participants, revealing that while both scopolamine and lorazepam impair memory, diphenhydramine does not, despite similar sed…

    DOI: 10.1007/s002130050482
  4. Accidental Polydipsia and Hyponatremia from Diphenhydramine Urinary Retention The American Journal of Medicine (2011) Thin

    This case report describes a 66-year-old man who developed hyponatremia and obstructive uropathy after ingesting diphenhydramine and excessive water, highlighting the risks associated with antihistamine use in patients with urinary retention.

    DOI: 10.1016/j.amjmed.2011.02.019
  5. CSACI position statement: Newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria Allergy, Asthma & Clinical Immunology (2019) commentary Strong

    This CSACI position statement concludes that newer generation H1-antihistamines are safer, faster-acting and more efficacious than first-generation agents, and should be first-line therapy for allergic rhinitis and urticaria.

    DOI: 10.1186/s13223-019-0375-9

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →